Editorials |
From The Feinstein Institute for Medical Research, Long Island Jewish Medical Center Campus, New Hyde Park; and Department of Medicine, The Albert Einstein College of Medicine, Bronx, NY.
Correspondence to Saul R. Powell, PhD, FAHA, Department of Medicine, Long Island Jewish Medical Center, 270-05 76th Ave, Rm B-387, New Hyde Park, NY 11042. E-mail spowell@lij.edu
See related articles, pages 362371 and 372380
Key Words: cardiac ubiquitinproteasome system regulation immunoproteasome phosphorylation
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Significance of UbiquitinProteasomeMediated Degradation of Proteins |
|---|
-NH2 group of an internal substrate lysine residue. This is a multistep process that has been reviewed in detail elsewhere.1,2 What has become clear is that the rapid destruction of these proteins, some with high biological activity, actually represents a form of regulation of cellular processes. The UPS is now recognized as a regulator of the cell cycle and cell division,3 immune response and antigen presentation,4 apoptosis,5 and cell signaling.6,7 Moreover, the UPS plays critical roles in protein quality by removal of damaged, oxidized, and/or misfolded proteins.8,9 Ciechanover et al10 have aptly referred to this process as "biological regulation via destruction." Over the past few years, it has become increasingly clear that this critical regulatory system becomes dysfunctional in certain disease states, such as Alzheimers disease, Huntingdons disease, and amyotrophic lateral sclerosis.11 With respect to the cardiovascular system, recent studies have suggested that myocardial ischemia,12,13 certain mutant proteinassociated cardiomyopathies,14 atherosclerosis,15 and even diabetes16 may be examples of proteasomal dysfunction disorders.
Despite all of the evidence supporting the critical role that the UPS plays in these processes, little is know about how the 26S proteasome itself is regulated. The majority of studies
Related Article:
Circ. Res. 2006 99: 362-371.
This article has been cited by other articles:
![]() |
N. C. Moss, W. E. Stansfield, M. S. Willis, R.-H. Tang, and C. H. Selzman IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2248 - H2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann, L. O. Lerman, and A. Lerman Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation Circ. Res., May 11, 2007; 100(9): 1276 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang and J. Robbins Heart Failure and Protein Quality Control Circ. Res., December 8, 2006; 99(12): 1315 - 1328. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |